REFERENCE
Brodszky V, Kárpáti K, Májer I, Nagy V, Farsang C, Gulácsi L.Cost-effectiveness of indapamide monotherapy in stroke prevention in Hungary Journal of Hypertension 25 (Suppl. 2): 222, Jun 2007
Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B.An amlodipine-based regimen is cost-effective compared to an atenolol-based regimen: results from the anglo-scandinavian cardiac outcomes trial Journal of Hypertension 25 (Suppl. 2): 137, Jun 2007
Rights and permissions
About this article
Cite this article
News from ESH. Pharmacoecon. Outcomes News 533, 7 (2007). https://doi.org/10.1007/BF03296130
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03296130